Literature DB >> 8029172

Invasive pulmonary aspergillosis: a rare presentation of non-Hodgkin's lymphoma.

M Garcia-Gonzalez1, A L Sanroman, R Arribas, G Torres, C Cuesta, V F Moreira.   

Abstract

We describe a patient with rapidly progressive pneumonia and a high level of serum lactate dehydrogenase, in whom postmortem study revealed the presence of a diffuse, small and large-cell multicentric non-Hodgkin's lymphoma, together with an invasive pulmonary aspergillosis. Aspergillosis is rare as a presenting feature of a lymphoproliferative disease; only one previous case has been reported to the best of our knowledge. Invasive aspergillosis and lymphoma should be considered in patients presenting with pneumonia and high level of lactate dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8029172      PMCID: PMC2397714          DOI: 10.1136/pgmj.70.824.459

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  12 in total

1.  Serum LDH activity in pulmonary embolism diagnosis.

Authors:  W E WACKER; P J SNODGRASS
Journal:  JAMA       Date:  1960-12-24       Impact factor: 56.272

2.  10 year review of invasive aspergillosis detected at necropsy.

Authors:  A P Boon; D O'Brien; D H Adams
Journal:  J Clin Pathol       Date:  1991-06       Impact factor: 3.411

3.  Immunohistochemical expression of galactomannan in the cytoplasm of phagocytic cells during invasive aspergillosis.

Authors:  G E Piérard; J Arrese Estrada; C Piérard-Franchimont; A Thiry; D Stynen
Journal:  Am J Clin Pathol       Date:  1991-09       Impact factor: 2.493

4.  Interstitial lung disease in lymphoproliferative disorders.

Authors:  G Majumdar; A K Singh
Journal:  Eur J Haematol       Date:  1991-01       Impact factor: 2.997

Review 5.  Aspergillosis. The spectrum of the disease in 98 patients.

Authors:  R C Young; J E Bennett; C L Vogel; P P Carbone; V T DeVita
Journal:  Medicine (Baltimore)       Date:  1970-03       Impact factor: 1.889

6.  Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia.

Authors:  S L Gerson; G H Talbot; S Hurwitz; B L Strom; E J Lusk; P A Cassileth
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

7.  Causes of death in patients with non-Hodgkin's lymphoma.

Authors:  S Ostrow; C H Diggs; J Sutherland; P H Wiernik
Journal:  Cancer       Date:  1981-08-01       Impact factor: 6.860

8.  Primary pulmonary malignant lymphoma, clinical and pathological findings, immunocytochemical and ultrastructural studies in 15 cases.

Authors:  A Le Tourneau; J Audouin; L Garbe; F Capron; B Servais; G Monges; H Payan; J Diebold
Journal:  Hematol Oncol       Date:  1983 Jan-Mar       Impact factor: 5.271

9.  Patho-radiologic correlation of invasive pulmonary aspergillosis in the compromised host.

Authors:  D P Orr; R L Myerowitz; P J Dubois
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

10.  Immunoblastic peripheral T-cell lymphoma confined to bone marrow in an infant presenting with aspergillosis.

Authors:  R Nuss; R C Ribeiro; N Bunin; F Behm; J Jenkins; C Berard; S B Murphy
Journal:  Med Pediatr Oncol       Date:  1988
View more
  3 in total

1.  Primary invasive aspergillosis with disseminated intravascular coagulation as a presenting feature of non-Hodgkin's lymphoma.

Authors:  Margaret Balsitis; Maha Elgoweini; Sarah J Martin; Gillian S Shankland; Jane Paxton; Abhijit M Bal
Journal:  Med Mycol Case Rep       Date:  2015-07-02

2.  Intravascular large B-cell lymphoma complicated by invasive pulmonary aspergillosis: a rare presentation.

Authors:  Tamadur Mahasneh; Zinta Harrington; Jonathan Williamson; Darweesh Alkhawaja; Jo Duflou; Joo-Shik Shin
Journal:  Respirol Case Rep       Date:  2014-02-25

Review 3.  Simultaneous occurrence of invasive pulmonary aspergillosis and diffuse large B-cell lymphoma: case report and literature review.

Authors:  Lianyou Shao; Longxiang Jiang; Siyao Wu; Lihua Yu; Liangxing Wang; Xiaoying Huang
Journal:  BMC Cancer       Date:  2020-01-06       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.